The Life Insurance Market
Life insurance may be less expensive for men in future thanks to developments in the treatment of prostate cancer, which could end up saving lives.
The University of Cardiff in Wales has run clinical trials of 1,200 participants in which male patients were given radiation treatment on top of hormonal therapy.
People looking into the possibility of getting critical illness cover will be pleased to learn the addition of radiotherapy resulted in 43 per cent fewer fatalities over a seven year period.
Of the men who had hormone treatment alone, 79 per cent were still living seven years after the trials, whereas those who had radiotherapy had a 90 per cent survival rate.
Despite the improvements in treatments and survival rates - income protection would be a wise move, as a quarter of all new cases of cancer diagnosed in men are found within the prostate.
Post your own comment